Scott Carmer
Keine laufenden Positionen mehr
Karriereverlauf von Scott Carmer
Ehemalige bekannte Positionen von Scott Carmer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEXIMMUNE, INC. | Director/Board Member | 01.01.2017 | 12.02.2022 |
Chief Executive Officer | 01.03.2018 | 12.02.2022 | |
Chief Operating Officer | 01.07.2015 | 01.03.2018 | |
Corporate Officer/Principal | 01.02.2014 | 01.07.2015 | |
President | 01.03.2018 | 12.02.2022 | |
Orgenesis Maryland, Inc.
Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Chief Executive Officer | 04.08.2014 | 18.11.2016 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 11.04.2011 | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | - | - |
Ausbildung von Scott Carmer
University of Kentucky | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMGEN INC. | Health Technology |
NEXIMMUNE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Orgenesis Maryland, Inc.
Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Health Technology |
- Börse
- Insiders
- Scott Carmer
- Erfahrung